Discovery of Biaryl Amide Derivatives as Potent, Selective, and Orally Bioavailable RORγt Agonists for Cancer Immunotherapy.
Lu L, Huang Y, Song M, Sun N, Xia L, Yu M, Zhao M, Qiu R, Chen JA, Zhao Y, Wang H, Guo H, Li Y, Zhu D, Wang Y, Xie Q.
Lu L, et al. Among authors: xia l.
J Med Chem. 2023 Dec 14;66(23):16091-16108. doi: 10.1021/acs.jmedchem.3c01492. Epub 2023 Nov 20.
J Med Chem. 2023.
PMID: 37982494